NEW YORK ( TheStreet) -- CHANGE IN RATINGSArbor Realty Trust ( ABR) upgraded to hold at TheStreet ratings. Allergan ( AGN) rated new Hold at Canaccord. Valuation call, based on a $101 price target. Baxter ( BAX) rated new Outperform at BMO. $70 price target. Company has a solid pipeline and can deliver consistent, long-term growth. A.M. Castle ( CAS) upgraded to hold at TheStreet ratings. Clean Energy ( CLNE) rated new Hold at Keybanc. Company lacks potential near-term catalysts. CSX ( CSX) downgraded at UBS to Neutral from Buy, UBS said. $24.50 price target. Catalyst lacking and Q3 estimates falling. Dover ( DOV) rated new Buy at Capstone. $71 price target. Company is focused on targeted growth areas. FMC ( FMC) rated new Neutral at Goldman. Valuation call, based on a $62 price target. Corning ( GLW) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $16 price target. LCD glass cycle appears to be bottoming and the company is cutting back on capital spending. Hasbro ( HAS) downgraded at Needham from Buy to Hold, Needham said. Valuation call. Kansas City Southern ( KSU) downgraded at UBS to Sell from Neutral, UBS said. $74 price target. Lack of catalyst and trades at premium to peers. Lam Research ( LRCX) downgraded at Citigroup to Neutral from Buy, Citigroup said. $34 price target. Apple's shift to TSMC from Samsung could be negative. Marathon Oil ( MRO) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $37 price target. Estimates also boosted, as the Paloma acquisition should add to earnings. Norfolk Southern ( NSC) downgraded at UBS to Neutral from Buy, UBS said. $79 price target. Valuation trap lacking compelling investment case. Northern Trust ( NTRS) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based $40 price target. Charles Schwab ( SCHW) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company is leveraged to lower RMBS yields. $14 price target. St. Jude ( STJ) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. ICD market is stabilizing and the company should benefit from a weaker dollar. Union Pacific ( UNP) downgraded at UBS to Neutral from Buy, UBS said. $135 price target. Premium valuation moves us to sidelines.